SOPHARMA (SPH): Current report 112 re insiders transactions - raport 112
UNI - EN REPORT No112/2013
The Board of Directors of Sopharma AD (the “Company”) announces that it was notified by Mr Ognian Donev, Chairman of the Board of Directors that the company ELPHARMA related to him, executed the following transactions related to shares of the Company:
Date and
time of Operation Number Unit price
settlement of shares (BGN)
14.8.2013 Sale 1 000 3.2900
14.8.2013 Sale 6 000 3.2900
16.8.2013 Sale 4 400 3.2900
16.8.2013 Sale 600 3.2900
16.8.2013 Sale 5 700 3.2900
19.8.2013 Sale 600 3.2900
19.8.2013 Sale 5 700 3.2900
19.8.2013 Sale 600 3.2900
19.8.2013 Sale 5 700 3.2900
19.8.2013 Sale 600 3.2900
19.8.2013 Sale 5 700 3.2900
19.8.2013 Sale 300 3.2950
19.8.2013 Sale 200 3.2950
19.8.2013 Sale 6 000 3.2950
19.8.2013 Sale 3 800 3.2950
19.8.2013 Sale 6 000 3.2950
19.8.2013 Sale 6 000 3.2950
19.8.2013 Sale 3 235 3.2950
19.8.2013 Sale 5 500 3.2950
19.8.2013 Sale 6 000 3.2950
19.8.2013 Sale 5 995 3.2950
The transfer of the above-mentioned shares was executed on the Bulgarian Stock Exchange in Sofia (regulated market) by way of electronic trade.
Legal grounds: Art.160.4 of the Act on Trading in Financial Instruments of 29 July 2005.
Signatures of individuals authorized to represent the Company:
Ognian Donev
